Innovative approximate analytical solution for standard model of viral dynamics: hepatitis C with direct-acting agents as an implemented case (Q2298065)

From MaRDI portal





scientific article; zbMATH DE number 7170446
Language Label Description Also known as
default for all languages
No label defined
    English
    Innovative approximate analytical solution for standard model of viral dynamics: hepatitis C with direct-acting agents as an implemented case
    scientific article; zbMATH DE number 7170446

      Statements

      Innovative approximate analytical solution for standard model of viral dynamics: hepatitis C with direct-acting agents as an implemented case (English)
      0 references
      0 references
      0 references
      0 references
      0 references
      20 February 2020
      0 references
      Summary: In this article, a novel approximate analytical solution is presented for solving the standard viral dynamic model. Basically, the standard model is used to study viral dynamics in patients for a wide range of viruses like HIV, HPV, HBV, and HCV. In this research work, the standard model for hepatitis C virus (HCV) is considered in detail; however, the analysis and results can be applicable for all other viruses. This standard model is used to study viral dynamics in patients treated with direct-acting antiviral agents (DAAs). Power series solution combined with Laplace-Padé resummation method (PSLP) is used to obtain the approximate analytical solutions for the model. To test the capability as well as the validity of the proposed method, results are compared with available viral load data published in the literature and with published simulation results. Good fits are obtained in the comparison for all cases considered. Given that medical specialists and physicians are more interested in solutions that yield direct and simple predictions, it is expected that the proposed approximate analytical solution would be attractive to them and help them to obtain a straightforward and a proper estimation regarding the viral load due to variations in treatment and/or patient's parameters.
      0 references

      Identifiers

      0 references
      0 references
      0 references
      0 references
      0 references
      0 references
      0 references